Brian Mann
-
As addiction has soared, drugmakers, distributors and pharmacies profited off opioids. Newly released data details who made the pills, where they were sold, and which communities were hit hardest.
-
The deal to resolve all U.S. federal investigations and claims is the biggest drug industry settlement so far stemming from the nation's deadly opioid epidemic.
-
Drug companies are paying hundreds of millions of dollars to end lawsuits tied to the opioid epidemic. As payouts grow, government leaders are fighting over where the money should go.
-
If finalized, such a deal could funnel tens of billions of dollars to American communities struggling with the addiction crisis, while restoring stability to one of the country's biggest industries.
-
Opioid manufacturers are facing dozens of lawsuits from state and local governments that blame them for the cost of the epidemic. Lawyers for both sides are due at trial in the coming year.
-
British drugmaker Indivior faces felony charges after allegedly trying to falsely convince doctors that its opioid products were safer than cheaper generic alternatives.
-
According to a new NPR/Ipsos opioid poll, 71% of Americans surveyed also say the government should do more to curb the epidemic.
-
The federal government is charging the maker of the addiction drug Suboxone with fraud and conspiracy in marketing the drug to doctors.
-
Federal prosecutors charge British drug maker Indivior with felony fraud and conspiracy for its marketing of opioid addiction products including Suboxone.
-
Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies' reputations. Litigation has forced the release of internal documents that are shifting the narrative.